Feasibility, safety, and tolerability of two modalities of plasma exchange with albumin replacement to treat elderly patients with Alzheimer's disease in the AMBAR study

BACKGROUND: In the Alzheimer Management by Albumin Replacement (AMBAR) study, mild‐to‐moderate Alzheimer's disease (AD) patients were treated with a plasma exchange (PE) program. Feasibility and safety of PE in this specific population are poorly understood and were analyzed in detail in this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Boada, Mercè, Kiprov, Dobri, Anaya, Fernando, López, Oscar L., Núñez, Laura, Olazarán, Javier, Lima, José, Grifols, Carlota, Barceló, Miquel, Rohe, Regina, Prieto‐Fernández, Cristina, Szczepiorkowski, Zbigniew M., Páez, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092802/
https://www.ncbi.nlm.nih.gov/pubmed/36305459
http://dx.doi.org/10.1002/jca.22026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092802/
https://www.ncbi.nlm.nih.gov/pubmed/36305459
http://dx.doi.org/10.1002/jca.22026

Ejemplares similares